PIP
TEVA icon

Palisades Investment Partners’s Teva Pharmaceuticals TEVA Stock Holding History

Palisades Investment Partners’s Portfolio TEVA Stock Details TEVA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2014
Q2 		$199K Sell
3,800
-3,800
-50% -$194K 0.35% 80
2014
Q1 		$402K Buy
+7,600
New +$351K 0.44% 79

Other funds holding TEVA

Franklin Resources
Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return
Norges Bank
Norges Bank Oslo, Norway $935B AUM
MIP
Mondrian Investment Partners London, United Kingdom $6.48B AUM 18.36% 1-Year Est. Return
Lazard Asset Management
Lazard Asset Management New York $60.8B AUM 22.47% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
Allianz Asset Management
Allianz Asset Management Munich, Germany $95.4B AUM 38.74% 1-Year Est. Return
PC
PointState Capital New York $7.9B AUM 42.31% 1-Year Est. Return

Palisades Investment Partners's TEVA Position: Q2 2014 in Review

Palisades Investment Partners reduced its Teva Pharmaceuticals (TEVA) stake by 50% in Q2 2014, selling an estimated $194K and leaving 3,800 shares worth $199K. The position accounts for 0.35% of the portfolio, ranked #80.

Palisades Investment Partners first reported a position in TEVA in Q1 2014 and has held it in 2 quarters since. The position peaked at $402K in Q1 2014. 780 funds tracked by Wall St. Rank hold TEVA as of Q2 2014.

  • Palisades Investment Partners held 3,800 shares of Teva Pharmaceuticals worth $199K as of Q2 2014.
  • Palisades Investment Partners sold 3,800 Teva Pharmaceuticals shares in Q2 2014, an estimated $194K.
  • Teva Pharmaceuticals made up 0.35% of Palisades Investment Partners's portfolio in Q2 2014, its #80 holding.
  • Palisades Investment Partners first reported a position in Teva Pharmaceuticals in Q1 2014 and has held it in 2 quarters since.
  • Palisades Investment Partners's Teva Pharmaceuticals position peaked at $402K in Q1 2014.
  • 780 funds tracked by Wall St. Rank held Teva Pharmaceuticals as of Q2 2014.

Based on Palisades Investment Partners's 13F filing for Q2 2014, filed 28 Jul 2014.